Low-molecular-weight heparins for treatment of deep vein thrombosis. 1997

B J Chaffee
Infusion Service, Specialized Pharmacy Services, Livonia, MI 48151-3347, USA.

UI MeSH Term Description Entries
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018579 Patient Selection Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols. Patient Recruitment,Research Subject Recruitment,Selection Criteria,Research Subject Selection,Selection for Treatment,Selection of Research Volunteers,Selection of Subjects,Criteria, Selection,Recruitment, Patient,Recruitment, Research Subject,Recruitments, Research Subject,Research Subject Recruitments,Research Subject Selections,Research Volunteers Selection,Research Volunteers Selections,Selection for Treatments,Selection, Patient,Selection, Research Subject,Selections, Research Subject,Subject Recruitment, Research,Subject Recruitments, Research,Subject Selection, Research,Subject Selections, Research,Subjects Selection,Subjects Selections,Treatment, Selection for,Treatments, Selection for,Volunteers Selection, Research
D018718 Home Infusion Therapy Use of any infusion therapy on an ambulatory, outpatient, or other non-institutionalized basis. Infusion Therapy, Home,Outpatient Infusion Therapy,Therapy, Home Infusion,Home Infusion Therapies,Infusion Therapies, Home,Infusion Therapies, Outpatient,Infusion Therapy, Outpatient,Outpatient Infusion Therapies,Therapies, Home Infusion,Therapies, Outpatient Infusion,Therapy, Outpatient Infusion

Related Publications

B J Chaffee
November 2001, The American journal of managed care,
B J Chaffee
May 1998, The Annals of pharmacotherapy,
B J Chaffee
January 1992, Advances in experimental medicine and biology,
B J Chaffee
March 1996, International angiology : a journal of the International Union of Angiology,
B J Chaffee
March 2003, Anales de medicina interna (Madrid, Spain : 1984),
B J Chaffee
January 1999, Seminars in thrombosis and hemostasis,
B J Chaffee
March 1998, The Western journal of medicine,
B J Chaffee
January 1999, Seminars in thrombosis and hemostasis,
Copied contents to your clipboard!